KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 8.36
-0.09 (-1.07%)
Nov 13, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 681.69 | 1,237 | 2,271 | 1,500 | 1,678 | 1,574 |
Trading Asset Securities | 690.65 | 1,109 | 471.28 | 603.8 | 319.4 | 160.5 |
Cash & Short-Term Investments | 1,372 | 2,347 | 2,742 | 2,103 | 1,997 | 1,735 |
Cash Growth | -50.27% | -14.42% | 30.36% | 5.32% | 15.12% | -4.68% |
Accounts Receivable | 3,304 | 3,527 | 3,855 | 3,225 | 2,625 | 2,011 |
Other Receivables | 151.6 | 188.15 | 123.73 | 797.75 | 95.1 | 169.09 |
Receivables | 3,456 | 3,716 | 3,979 | 4,022 | 2,720 | 2,180 |
Inventory | 1,404 | 1,383 | 1,540 | 1,772 | 1,681 | 1,884 |
Other Current Assets | 327.69 | 278.66 | 294.82 | 250.14 | 369 | 381.96 |
Total Current Assets | 6,559 | 7,724 | 8,555 | 8,148 | 6,766 | 6,180 |
Property, Plant & Equipment | 1,183 | 1,252 | 1,286 | 1,307 | 1,291 | 1,361 |
Long-Term Investments | 238.05 | 377.22 | 305.46 | 319.61 | 320.61 | 278.24 |
Goodwill | 1,497 | 1,499 | 1,503 | 1,503 | 91.73 | 91.73 |
Other Intangible Assets | 344.63 | 373.31 | 412.22 | 441.97 | 355.98 | 408.88 |
Long-Term Deferred Tax Assets | 327.65 | 216.31 | 258.28 | 269.12 | 245.6 | 233.83 |
Long-Term Deferred Charges | 299.49 | 270.03 | 237.84 | 237 | 199.07 | 274.49 |
Other Long-Term Assets | 75.04 | 62.01 | 53.12 | 69.83 | 161.17 | 64.98 |
Total Assets | 10,524 | 11,774 | 12,611 | 12,295 | 9,432 | 8,893 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 822.59 | 876.24 | 1,056 | 936.78 | 977.12 | 1,239 |
Accrued Expenses | 224.44 | 1,522 | 1,831 | 1,597 | 1,262 | 1,117 |
Short-Term Debt | 669.12 | 813.37 | 658.04 | 725.49 | 912.76 | 641.75 |
Current Portion of Long-Term Debt | 100.91 | 109.19 | 61.05 | 1 | 99.5 | 0.2 |
Current Portion of Leases | - | 25.98 | 19.28 | 22.46 | 22.57 | 36.07 |
Current Income Taxes Payable | 42.34 | 51.48 | 158.94 | 149.75 | 78.76 | 93.28 |
Current Unearned Revenue | 104.76 | 51.46 | 83.32 | 102.63 | 186.37 | 74.09 |
Other Current Liabilities | 1,149 | 375.56 | 1,624 | 329.7 | 350.01 | 284.76 |
Total Current Liabilities | 3,113 | 3,826 | 5,491 | 3,865 | 3,889 | 3,485 |
Long-Term Debt | 677.18 | 683.24 | 46.05 | 107.56 | 60 | 99.5 |
Long-Term Leases | 31.12 | 53.42 | 48.59 | 44.24 | 44.77 | 50.47 |
Long-Term Unearned Revenue | 235.57 | 243.24 | 229.92 | 224.09 | 207.58 | 245.34 |
Long-Term Deferred Tax Liabilities | 18.53 | 21.64 | 21.65 | 24.28 | 10.64 | 15.42 |
Other Long-Term Liabilities | 4.96 | 4.93 | 28.03 | 75.97 | 77.58 | 56.67 |
Total Liabilities | 4,080 | 4,832 | 5,865 | 4,341 | 4,289 | 3,953 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 756.98 | 756.98 | 756.98 | 757.99 | 758.26 | 758.26 |
Additional Paid-In Capital | 522.1 | 519.66 | 520.62 | 2,327 | 1,161 | 1,169 |
Retained Earnings | 3,613 | 4,114 | 3,981 | 3,490 | 3,071 | 2,894 |
Treasury Stock | - | - | - | -10.42 | -13.15 | -26.3 |
Comprehensive Income & Other | -29.87 | -28.67 | -5.29 | -1.62 | 6.3 | -11.5 |
Total Common Equity | 4,862 | 5,362 | 5,254 | 6,562 | 4,983 | 4,783 |
Minority Interest | 1,582 | 1,579 | 1,493 | 1,392 | 159.5 | 156.98 |
Shareholders' Equity | 6,444 | 6,941 | 6,746 | 7,954 | 5,143 | 4,940 |
Total Liabilities & Equity | 10,524 | 11,774 | 12,611 | 12,295 | 9,432 | 8,893 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,478 | 1,685 | 833.02 | 900.74 | 1,140 | 828 |
Net Cash (Debt) | -105.99 | 661.31 | 1,909 | 1,203 | 857.4 | 906.76 |
Net Cash Growth | - | -65.35% | 58.73% | 40.26% | -5.44% | -9.49% |
Net Cash Per Share | -0.14 | 0.87 | 2.53 | 1.58 | 1.14 | 1.20 |
Filing Date Shares Outstanding | 756.98 | 756.98 | 756.98 | 757.11 | 758.13 | 758.26 |
Total Common Shares Outstanding | 756.98 | 756.98 | 756.98 | 757.99 | 758.26 | 758.26 |
Working Capital | 3,446 | 3,898 | 3,064 | 4,283 | 2,878 | 2,695 |
Book Value Per Share | 6.42 | 7.08 | 6.94 | 8.66 | 6.57 | 6.31 |
Tangible Book Value | 3,021 | 3,490 | 3,338 | 4,617 | 4,535 | 4,283 |
Tangible Book Value Per Share | 3.99 | 4.61 | 4.41 | 6.09 | 5.98 | 5.65 |
Buildings | - | 1,338 | 1,325 | 1,262 | 1,137 | 1,136 |
Machinery | - | 1,059 | 1,058 | 1,011 | 988.66 | 980.07 |
Construction In Progress | - | 100.4 | 76.46 | 100.51 | 64.65 | 43.51 |